← Leaderboards
Marcos I. Restrepo
University Of Texas Hlth Science Center
$688,500
Attributed
$688,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $137.7K · FY2010–14$200K$150K$100K$50K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$688,500 · 1
By mechanism
K23$688,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- Yohannes T Ghebre$4,651,148
- Peter J Houghton$32,798,876
- Andrew Duncan Joseph Meyer$924,720
- Zhu Wang$476,290
- Habil Zare$215,308
Others in their field
Top investigators on “Accounting”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$185,928,938
- Zeljko Ivezic · University Of Washington$142,654,512
- Victor Krabbendam · Association Of Universities For Research In Astronomy, Inc.$142,654,512
- Steven M Kahn · Association Of Universities For Research In Astronomy, Inc.$142,654,512
Research focus
AccountingAntimicrobialCareerCareer DevelopmentCessation Of LifeClinical PracticeCommunicable DiseasesCommunitiesCostCytokineDatabasesDesignDevelopment PlansEpidemiologic StudiesFundingFutureGeneticHospitalsImmune ResponseImmunomodulatorsImmunoregulationInfectionInflammationAbstracting
Grant awards (5)
Effect of macrolides as immunomodulators in patients with sepsis and pneumonia$137,700
K23 · FY2014 · HL · contact PI
Effect of macrolides as immunomodulators in patients with sepsis and pneumonia$137,700
K23 · FY2013 · HL · contact PI
Effect of macrolides as immunomodulators in patients with sepsis and pneumonia$137,700
K23 · FY2012 · HL · contact PI
Effect of macrolides as immunomodulators in patients with sepsis and pneumonia$137,700
K23 · FY2011 · HL · contact PI
Effect of macrolides as immunomodulators in patients with sepsis and pneumonia$137,700
K23 · FY2010 · HL · contact PI